Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
- PMID: 29926527
- PMCID: PMC6089187
- DOI: 10.1002/cam4.1594
Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
Abstract
Vacuolar ATPase (V-ATPase) is an ATP-dependent H+ -transporter that pumps protons across intracellular and plasma membranes. It consists of a large multi-subunit protein complex and influences a wide range of cellular processes. This review focuses on emerging evidence for the roles for V-ATPase in cancer. This includes how V-ATPase dysregulation contributes to cancer growth, metastasis, invasion and proliferation, and the potential link between V-ATPase and the development of drug resistance.
Keywords: V-ATPase; cancer; drug resistance; invasion; metastasis; novel therapy.
© 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6089187/bin/CAM4-7-3800-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6089187/bin/CAM4-7-3800-g002.gif)
Similar articles
-
Regulation and function of V-ATPases in physiology and disease.Biochim Biophys Acta Biomembr. 2020 Dec 1;1862(12):183341. doi: 10.1016/j.bbamem.2020.183341. Epub 2020 May 16. Biochim Biophys Acta Biomembr. 2020. PMID: 32422136 Free PMC article. Review.
-
Myrtenal-induced V-ATPase inhibition - A toxicity mechanism behind tumor cell death and suppressed migration and invasion in melanoma.Biochim Biophys Acta Gen Subj. 2019 Jan;1863(1):1-12. doi: 10.1016/j.bbagen.2018.09.006. Epub 2018 Sep 11. Biochim Biophys Acta Gen Subj. 2019. PMID: 30279148
-
The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells.J Biol Chem. 2013 Nov 8;288(45):32731-32741. doi: 10.1074/jbc.M113.503771. Epub 2013 Sep 26. J Biol Chem. 2013. PMID: 24072707 Free PMC article.
-
Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion.Int J Cancer. 2013 Jan 15;132(2):E1-10. doi: 10.1002/ijc.27811. Epub 2012 Sep 21. Int J Cancer. 2013. PMID: 22945374 Free PMC article.
-
Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer.Curr Pharm Des. 2012;18(10):1383-94. doi: 10.2174/138161212799504821. Curr Pharm Des. 2012. PMID: 22360554 Review.
Cited by
-
Deregulation of New Cell Death Mechanisms in Leukemia.Cancers (Basel). 2024 Apr 25;16(9):1657. doi: 10.3390/cancers16091657. Cancers (Basel). 2024. PMID: 38730609 Free PMC article. Review.
-
Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma.BMC Genomics. 2024 Apr 17;25(1):379. doi: 10.1186/s12864-024-10283-5. BMC Genomics. 2024. PMID: 38632516 Free PMC article.
-
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights.Med Oncol. 2024 Apr 9;41(5):108. doi: 10.1007/s12032-024-02313-9. Med Oncol. 2024. PMID: 38592406 Review.
-
Assessing the Therapeutic Efficacy of Proton Transport Inhibitors in a Triple-Negative Breast Cancer Murine Model with Magnetic Resonance Imaging-Chemical Exchange Saturation Transfer Tumor pH Imaging.Metabolites. 2023 Nov 18;13(11):1161. doi: 10.3390/metabo13111161. Metabolites. 2023. PMID: 37999256 Free PMC article.
-
Innate lymphoid cells and tumor-derived lactic acid: novel contenders in an enduring game.Front Immunol. 2023 Oct 5;14:1236301. doi: 10.3389/fimmu.2023.1236301. eCollection 2023. Front Immunol. 2023. PMID: 37868977 Free PMC article. Review.
References
-
- Sun‐Wada G‐H, Wada Y. Role of vacuolar‐type proton ATPase in signal transduction. Biochim Biophys Acta. 2015;1847:1166‐1172. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources